mbg-logo-500px

Maxwell Biotech Group currently has 9 biotech companies in its portfolio, which are engaged in the development of 11 innovative clinical stage drugs. 

mbg-portfolio-sidebar-hepaterambg-portfolio-sidebar-neuromaxmbg-portfolio-sidebar-infectexmbg-portfolio-sidebar-eleventambg-portfolio-sidebar-osterosmbg-portfolio-sidebar-photonicsmbg-portfolio-sidebar-oncomaxmbg-portfolio-sidebar-metamaxmbg-portfolio-sidebar-cardionova

TEAM

DMITRY POPOV

Managing partner

ALEXANDER ALEXANDROV

Medical director

ALEXEY ELISEEV

Venture partner

ALEXANDER POLINSKY

Venture partner

JEFFREY A. GELFAND

Advisor

ERIC K. ROWINSKY

Advisor

MARK HOFER

General Counsel

© Maxwell Biotech Group Ltd.

TOP